IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 140 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $179,000 | -80.9% | 11,380 | -77.0% | 0.04% | -82.3% |
| Q2 2017 | $936,000 | +327.4% | 49,580 | +286.4% | 0.20% | +314.3% |
| Q1 2017 | $219,000 | -63.1% | 12,830 | -67.0% | 0.05% | -65.2% |
| Q4 2016 | $594,000 | -72.8% | 38,830 | -71.8% | 0.14% | -73.1% |
| Q3 2016 | $2,187,000 | +21.4% | 137,757 | 0.0% | 0.52% | +21.2% |
| Q2 2016 | $1,801,000 | +107.2% | 137,757 | +73.5% | 0.43% | +107.2% |
| Q1 2016 | $869,000 | -5.5% | 79,415 | 0.0% | 0.21% | -2.8% |
| Q4 2015 | $920,000 | +11.1% | 79,415 | 0.0% | 0.22% | +3.4% |
| Q3 2015 | $828,000 | -13.6% | 79,415 | 0.0% | 0.21% | -3.7% |
| Q2 2015 | $958,000 | -22.4% | 79,415 | +3.0% | 0.22% | -23.9% |
| Q1 2015 | $1,234,000 | -31.0% | 77,115 | -34.0% | 0.28% | -32.4% |
| Q4 2014 | $1,789,000 | +27.0% | 116,772 | +7.3% | 0.42% | +35.9% |
| Q3 2014 | $1,409,000 | -19.9% | 108,782 | -5.1% | 0.31% | -19.9% |
| Q2 2014 | $1,758,000 | +21.7% | 114,672 | -2.2% | 0.39% | +13.2% |
| Q1 2014 | $1,445,000 | – | 117,250 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |